For citation: Romanchishen A.F., Gostimsky A.V., Akinchev A.L., Karpatsky I.V., Matveeva Z.S., Vabalayte K.V. Oncological risk of recurrent goiter. Head and neck Russian Journal. 2019;7(1):12–17 (in Russian).
Doi: 10.25792/HN.2019.7.2.12–17
Purpose: to assess the risk of thyroid residue malignant change in patients with recurrent goi-ter, to substantiate the surgical tactics in this group of patients.
Material and methods: from 1973 to 2016, 28,138 patients with various thyroid diseases were operated in St. Petersburg Center for Endocrine Surgery and Oncology.
Results: in a retrospective analysis of a group consisting of 1106 patients with recurrent goi-ter, a new thyroid residue disease was registered in 156 (14.1%) cases. Thyroid cancer in the thyroid residue was detected in 57 (36.5%) patients or 5.2% of all patients with recurrent goi-ter. In this paper, we assessed the risk of thyroid residue malignant change in patients with recurrent goiter, and justified the surgical tactics in this group of patients. It was found that multinodular transformation of the thyroid residue and cicatrical changes in the area of the previous operation significantly decreased the opportunities of fine-needle aspiration biopsy. Findings. Active surgical tactics in case of detection of a multinodular transformation of the thyroid residue is justified. The operation of choice is thyroidectomy.
Key words: recurrent goiter, thyroid cancer
The authors declare no conflict of interest. Source of financing: not specified.
For citation: Romanchishen A.F., Gostimsky A.V., Akinchev A.L., Karpatsky I.V., Matveeva Z.S., Vabalayte K.V. Oncological risk of recurrent goiter. Head and neck Russian Journal. 2019;7(1):12–17 (in Russian).
The authors are responsible for the originality of the data presented and the possibility of pub-lishing illustrative material – tables, figures, photographs of patients.